Soligenix director surrenders options for 632 shares

Soligenix, Inc. director Anthony Gregg Lapointe surrendered stock options exercisable for an aggregate of 632 Common Stock shares to the issuer for cancellation on October 12, 2026, for no consideration.

Rhea-AI Filing Summary

Soligenix, Inc. director Anthony Gregg Lapointe surrendered stock options exercisable for an aggregate of 632 Common Stock shares to the issuer for cancellation on October 12, 2026, for no consideration. The option entries were reported as directly held, and no Rule 10b5-1 plan is reported. The six entries cover 54, 74, 128, 63, 121 and 192 underlying shares, respectively.

Insider Trade Summary

Disposition: 632 shares

Disposition 6 txns

Insider LAPOINTE ANTHONY GREGG

Role Director

Type	Security	Shares	Price	Value
Disposition	Stock Option (Right to Buy) F1	54	$0.00	$0.00
Disposition	Stock Option (Right to Buy)	74	$0.00	$0.00
Disposition	Stock Option (Right to Buy)	128	$0.00	$0.00
Disposition	Stock Option (Right to Buy)	63	$0.00	$0.00
Disposition	Stock Option (Right to Buy)	121	$0.00	$0.00
Disposition	Stock Option (Right to Buy)	192	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 0 contracts (Direct)

Footnotes (1)

1. F1. On October 12, 2026, the Reporting Person voluntarily surrendered stock options exercisable for an aggregate of 632 shares of Common Stock with exercise prices set forth in the table above to the Issuer for cancellation for no consideration. The cancellation is exempt from Section 16(b) of the Exchange Act pursuant to Rule 16b-3(e) and Rule 16b-6(d), and exempt from the reporting requirements of Section 16(a) pursuant to Rule 16a-4(d). The Reporting Person is voluntarily reporting this transaction.

Key Figures

Options surrendered for cancellation: 632 shares Option tranche: 54 underlying shares; $549.6000 exercise price Option tranche: 74 underlying shares; $400.8000 exercise price +4 more

7 metrics

Options surrendered for cancellation 632 shares Aggregate underlying Common Stock shares on October 12, 2026

Option tranche 54 underlying shares; $549.6000 exercise price Option surrendered for cancellation on October 12, 2026

Option tranche 74 underlying shares; $400.8000 exercise price Option surrendered for cancellation on October 12, 2026

Option tranche 128 underlying shares; $232.8000 exercise price Option surrendered for cancellation on October 12, 2026

Option tranche 63 underlying shares; $472.8000 exercise price Option surrendered for cancellation on October 12, 2026

Option tranche 121 underlying shares; $247.2000 exercise price Option surrendered for cancellation on October 12, 2026

Option tranche 192 underlying shares; $156.0000 exercise price Option surrendered for cancellation on October 12, 2026

Key Terms

Stock Option (Right to Buy), Rule 16b-3(e), Rule 16b-6(d)

3 terms

Stock Option (Right to Buy) technical

"Stock Option (Right to Buy)"

Rule 16b-3(e) regulatory

"exempt from Section 16(b) ... pursuant to Rule 16b-3(e)"

Rule 16b-6(d) regulatory

"exempt from Section 16(b) ... and Rule 16b-6(d)"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many SNGX options did director Anthony Gregg Lapointe surrender?

Anthony Gregg Lapointe, a Soligenix director, surrendered options exercisable for 632 shares of Common Stock to the issuer for cancellation on October 12, 2026, for no consideration. The six option entries covered 54, 74, 128, 63, 121 and 192 underlying shares. No Rule 10b5-1 plan is reported.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/13/2026 - 10:08 AM EDT Accepted by SEC EDGAR 10/13/2026 - 10:08 AM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LAPOINTE ANTHONY GREGG

(Last) (First) (Middle)

C/O SOLIGENIX, INC.

29 EMMONS DRIVE, SUITE B-10

(Street)

PRINCETON NEW JERSEY 08540

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
SOLIGENIX, INC. [ SNGX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$549.6	10/12/2026		D(1)	V		54	06/08/2017	06/07/2027	Common Stock	54	$0	0	D
Stock Option (Right to Buy)	$400.8	10/12/2026		D	V		74	09/27/2018	09/26/2028	Common Stock	74	$0	0	D
Stock Option (Right to Buy)	$232.8	10/12/2026		D	V		128	09/06/2019	09/05/2029	Common Stock	128	$0	0	D
Stock Option (Right to Buy)	$472.8	10/12/2026		D	V		63	09/16/2020	09/15/2030	Common Stock	63	$0	0	D
Stock Option (Right to Buy)	$247.2	10/12/2026		D	V		121	09/23/2021	09/22/2031	Common Stock	121	$0	0	D
Stock Option (Right to Buy)	$156	10/12/2026		D	V		192	11/17/2022	11/16/2032	Common Stock	192	$0	0	D

Explanation of Responses:

1. On October 12, 2026, the Reporting Person voluntarily surrendered stock options exercisable for an aggregate of 632 shares of Common Stock with exercise prices set forth in the table above to the Issuer for cancellation for no consideration. The cancellation is exempt from Section 16(b) of the Exchange Act pursuant to Rule 16b-3(e) and Rule 16b-6(d), and exempt from the reporting requirements of Section 16(a) pursuant to Rule 16a-4(d). The Reporting Person is voluntarily reporting this transaction.

	/s/ Gregg A. Lapointe	10/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)